Cedar Brook Financial Partners’s ViewRay, Inc. VRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-24,391
Closed -$8.59K 427
2023
Q2
$8.59K Hold
24,391
﹤0.01% 408
2023
Q1
$84.4K Hold
24,391
0.02% 380
2022
Q4
$109K Hold
24,391
0.03% 361
2022
Q3
$88.8K Hold
24,391
0.03% 342
2022
Q2
$65K Hold
24,391
0.02% 338
2022
Q1
$96K Hold
24,391
0.02% 370
2021
Q4
$134K Buy
24,391
+2,391
+11% +$14.6K 0.03% 370
2021
Q3
$159K Sell
22,000
-2,391
-10% -$15.1K 0.05% 335
2021
Q2
$161K Hold
24,391
0.05% 360
2021
Q1
$106K Buy
24,391
+2,391
+11% +$11.6K 0.04% 314
2020
Q4
$84K Hold
22,000
0.03% 319
2020
Q3
$77K Hold
22,000
0.03% 288
2020
Q2
$49K Sell
22,000
-1,000
-4% -$2.13K 0.02% 278
2020
Q1
$58K Buy
23,000
+2,000
+10% +$5.66K 0.03% 245
2019
Q4
$89K Hold
21,000
0.04% 286
2019
Q3
$61K Hold
21,000
0.03% 298
2019
Q2
$185K Hold
21,000
0.09% 287
2019
Q1
$155K Hold
21,000
0.08% 278
2018
Q4
$127K Buy
+21,000
New +$157K 0.08% 232

Other funds holding VRAY

Cedar Brook Financial Partners's VRAY Position: Q3 2023 in Review

Cedar Brook Financial Partners sold out of ViewRay, Inc. (VRAY) in Q3 2023, closing a stake of 24,391 shares — an estimated $8.59K sold.

Cedar Brook Financial Partners first reported a position in VRAY in Q4 2018 and held it in 19 quarters. The position peaked at $185K in Q2 2019. 11 funds tracked by Wall St. Rank hold VRAY as of Q3 2023.

  • Cedar Brook Financial Partners reported no remaining ViewRay, Inc. position as of Q3 2023 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 24,391 ViewRay, Inc. shares in Q3 2023, an estimated $8.59K.
  • Cedar Brook Financial Partners first reported a position in ViewRay, Inc. in Q4 2018 and held it in 19 quarters.
  • Cedar Brook Financial Partners's ViewRay, Inc. position peaked at $185K in Q2 2019.
  • 11 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q3 2023.

Based on Cedar Brook Financial Partners's 13F filing for Q3 2023, filed 17 Oct 2023.